Staying Real in Israel
Home of
"The Marty Roberts Show"

What a killer combination…A Chabadnik-owned company teamed up with Hadassah Hospital in Jerusalem…a match obviously made in Heaven…
The future of Lou Gehrig Disease is now in serious doubt, thank G-d!!

BrainStorm, Hadassah seal deal for trials of Lou Gehrig treatment

By Michael Rochvarger –Haaretz

The deal was concluded after an in-house committee at Hadassah Medical Center approved the proposed trials on humans. The trials however remain pending on approval from a Health Ministry committee that vets clinical trials on humans.

BrainStorm is controlled by Chabadnik businessman Chaim Lebovits.

By virtue of the deal between BrainStorm and Hadasit, Hadassah will put its top experts in neurology and stem cell science at BrainStorm’s disposal.

BrainStorm, in turn, will pick up NIS 5 million of the cost of the clinical trials, which follow satisfactory testing on laboratory animals based on a patented process through which stem cells from the patient’s own bone marrow are treated and turned into nerve cells in the laboratory. They are then injected back into the ALS patient.

The developers of the process hope to show that they can delay and even halt the progress of the disease through this treatment.

Stem cell medical developments are a major new frontier for the international medical community, providing the promise of the greatest breakthroughs in the treatment of disease since the development of antibiotics. Success for BrainStorm in developing a treatment for ALS is expected to open the door for the company to a $1 billion market. BrainStorm is trading in New York at a market cap of $30 million.

Since the latest paraclinical testing of its ALS treatment method began last September, the company’s stock price has shot up by 600%.